Blog
How can you measure behavior more accurately in your clinical trials?
Drug development typically relies upon clinical endpoints established within very controlled laboratory environments. Digital health technologies now provide the opportunity to transition data collection from the clinic into people’s personal lives, thereby providing more accurate conclusions about how a compound can influence their day-to-day life.
web-based testing,
wearables,
voice recognition,
voice,
virtual clinical trials,
technology,
swm,
subjective measures,
stress,
social cognition,
smartphones,
schizophrenia,
safety,
rvp,
rti,
research funding,
research,
remote testing,
recruitment,
psychosis,
prodromal,
pro-cognitive,
prm,
press release,
presenteeism,
precision psychiatry,
poster,
personalised medicine,
patient-centric,
patient recruitment,
parkinson's disease,
pal,
ots,
occupational health,
objective measures,
normative data,
neuroscience,
near-patient testing,
multiple sclerosis,
mts,
ms,
mental wellbeing,
mental health at work,
mental health,
mdd,
mci,
major depression,
machine learning,
longitudinal,
life at cambridge cognition,
international women's day,
hot cognition,
healthcare,
grant,
funding,
fatigue,
ert,
epidemiology,
ecoa,
ebt,
early career researchers,
early alzheimer's disease,
dms,
digital tools,
digital health,
depression,
dementia,
covid-19,
cognitive wellbeing,
cognitive testing,
cognitive science,
cognitive safety,
cognitive impairment,
cognitive function,
cognitive dysfunction,
cognitive deficits,
cognitive biomarkers,
cognitive assessment,
cognition kit,
cognition,
cns summit,
clinical trials,
clinical trial,
cias,
chronic illness,
chronic health conditions,
cgt,
cantab testimonial,
cantab research grant,
cantab,
cambridge cognition careers,
cambridge cognition,
brain health,
bipolar disorder,
biomarkers,
automatic speech recognition,
attention,
alzheimer's disease,
academic,
absenteeism,
